Management Team
- Colin Goddard, Ph.D.
Chief Executive Officer - Linda E. Amper, Ph.D.
Senior Vice President, Human Resources - Pierre Legault, BAA, MBA, CA3
Executive Vice President, Chief Financial Officer and Treasurer - Gabriel Leung
President, Pharmaceutical Business - Anker Lundemose, M.D., Ph.D. and D.Sc.
Executive Vice President of Corporate Development and Strategic Planning, OSI Pharmaceuticals, Inc.
Managing Director, OSI Investment Holdings GmbH - Jonathan Rachman, M.D., Ph.D..
Senior Vice President and Head of Diabetes/Obesity R&D - Robert Simon
Executive Vice President, Pharmaceutical Development & Manufacturing - Barbara A. Wood, Esq.
Senior Vice President, General Counsel and Secretary